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Diet quality in patients with end-stage kidney disease undergoing dialysis
Abstract
ACKGROUND: People on haemodialysis (HD) are at risk of consuming a poor quality diet. This includes
inadequate intake of omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA). OBJECTIVE: This study
aims to investigate diet quality, with a particular focus on n-3 LCPUFA intake, in a population of incentre HD
patients. DESIGN: Dietary intake was measured using three 24 hour recalls; the Polyunsaturated food
frequency questionnaire (PUFA FFQ) and the Total Diet Score (TDS). Dietary intake was also compared to
evidence based practice guidelines (EBPG). Nutritional status was assessed using the Patient Generated
Subjective Global Assessment (PG SGA). SUBJECTS: A total of 32 dialysis patients were recruited, from two
regional HD centres in New South Wales, Australia. MAIN OUTCOME MEASURE: Diet quality was the
main outcome measure. RESULTS: Diet quality of study participants was poor, with the majority not meeting
the EBPG for energy, protein and potassium. All participants exceeded the recommended amount of saturated
fat. The mean TDS of the dialysis cohort was 10.2, which was significantly higher than the TDS of 9.3 of a
healthy disease free cohort (p < 0.05). Positive correlations were found between TDS and LC omega-3 intake
(r = 0.392) and TDS and total omega-6 intake (r = 0.363). Only 22% of participants met the suggested dietary
target for n-3 LCPUFA intake. CONCLUSION: Dialysis patients in this study had suboptimal diet quality.
Improvements are required for better adherence to the EBPG. Increased consumption of n-3 LCPUFA fatty
acids may also be of benefit.
Keywords
end-stage, kidney, dialysis, disease, diet, quality, patients, undergoing
Disciplines
Medicine and Health Sciences | Social and Behavioral Sciences
Publication Details
Roach, L. A., Lambert, K., Holt, J. L. & Meyer, B. J. (2017). Diet quality in patients with end-stage kidney
disease undergoing dialysis. Journal of Renal Care, 43 (4), 226-234.
This journal article is available at Research Online: http://ro.uow.edu.au/smhpapers/5242
DIET QUALITY IN PATIENTS WITH END-STAGE KIDNEY DISEASE
UNDERGOING DIALYSIS
Lauren A. Roach1, Kelly Lambert2, Jane L. Holt3, Barbara J. Meyer1
1School of Medicine, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, New South
Wales, Australia
2Illawarra Shoalhaven Local Health District, Department of Clinical Nutrition, Wollongong, New South Wales,
Australia
3Illawarra Shoalhaven Local Health District, Renal Service, Wollongong, New South Wales, Australia
Roach L.A., Lambert K., Holt J.L., Meyer B.J. (2017). Diet quality in patients with end-stage kidney disease undergoing dialysis.
Journal of Renal Care 43(4), 226–234.
S U M M A R Y
Background: People on haemodialysis (HD) are at risk of consuming a poor quality diet. This includes inadequate intake of
omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA).
Objective: This study aims to investigate diet quality, with a particular focus on n-3 LCPUFA intake, in a population of incentre
HD patients.
Design: Dietary intake was measured using three 24 hour recalls; the Polyunsaturated food frequency questionnaire (PUFA
FFQ) and the Total Diet Score (TDS). Dietary intake was also compared to evidence based practice guidelines (EBPG).
Nutritional status was assessed using the Patient Generated Subjective Global Assessment (PG SGA).
Subjects: A total of 32 dialysis patients were recruited, from two regional HD centres in New South Wales, Australia.
Main Outcome Measure: Diet quality was the main outcome measure.
Results: Diet quality of study participants was poor, with the majority not meeting the EBPG for energy, protein and
potassium. All participants exceeded the recommended amount of saturated fat. The mean TDS of the dialysis cohort was
10.2,whichwas significantly higher than the TDS of 9.3 of a healthy disease free cohort (p<0.05). Positive correlationswere
found between TDS and LC omega-3 intake (r¼0.392) and TDS and total omega-6 intake (r¼0.363). Only 22% of
participants met the suggested dietary target for n-3 LCPUFA intake.
Conclusion: Dialysis patients in this study had suboptimal diet quality. Improvements are required for better adherence to
the EBPG. Increased consumption of n-3 LCPUFA fatty acids may also be of benefit.
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INTRODUCTION
Patients who are undertaking dialysis treatment are at risk of
consuming a poor-quality diet. Previous studies suggest low
adherence to evidence based dietary guidelines for people with
end-stage kidney disease (ESKD) (Khoueiry et al. 2011; Luis et al.
2016) and a high consumption of convenience foods (Butt et al.
2007).
LITERATURE REVIEW
The implications of a poor diet quality in patients undertaking
dialysis are far reaching. For example, excessive consumption
of saturated fat, salt and inadequate fibre intake in dialysis
cohorts has been described as characteristic of an atherogenic
diet (Khoueiry et al. 2011; Luis et al. 2016). This is of concern
for patients undertaking dialysis as they are a group who suffer
from a higher mortality rate from cardiovascular disease,
reported up to 40 times that of the normal population (Collins
2003). Poor nutritional status also leads to poor sleep quality
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(Burrowes et al. 2012) and poor quality of life (Zabel et al.
2012).
Of particular interest in those undertaking haemodialysis (HD) is
omega-3 (n-3) intake, especially levels of the long chain (LC) n-3
fatty acids eicosapentaenoicacid (EPA)anddocosahexaenoicacid
(DHA) as they have cardio protective properties (Friedman et al.
2008). Beneficial effects of n-3 LC polyunsaturated fatty acid (n-3
LCPUFA) supplementation in haemodialysis groups have been
reported previously, with supplementation for four months
resulting in reduced depressive symptoms and an increase in an
anti-inflammatory to pro-inflammatory ratio (Gharekhani et al.
2014). Previous studies in dialysis cohorts have described fish
intake (Saifullah et al. 2007; An et al. 2009; Madsen et al. 2011;
Dessı et al. 2014), PUFA intake (Khoueiry et al. 2011; Luis et al.
2016) and one reports total n-3 intake (Noori et al. 2011). To our
knowledge none of these studies have examined n-3 LCPUFA
intake specifically in patients undergoing dialysis.
Due to the limited knowledge in the literature, particularly
concerning n-3 LCPUFA intake this study aims to investigate diet
quality in a cohort of Australian patients undertaking dialysis, by:
1. Comparing dietary intake to the evidence based practice
guidelines (EBPG) (Ash et al. 2006; National Health and
Medical Research Council 2006; Fouque et al. 2007; Ash
et al. 2014);
2. Describing diet quality utilising a modified total diet score
(Russell et al. 2013);
3. Exploring the relationship between diet quality and fatty acid
intake;
4. and describing n-3 LCPUFA intake and the primary food
sources of n-3 LCPUFA.
METHODS
PARTICIPANTS
Participants were recruited from two satellite dialysis units in
regional New SouthWales, Australia. These units provide in centre
haemodialysis to approximately 130 people. All participants
reviewed a participant information sheet and gave informed
consent. Inclusion criteria were patients stable on maintenance
haemodialysis for at least three months, and capable of
understanding and answering the questionnaires. Excluded were
patients with a diagnosis that would prevent them from accurately
answering the questionnaires, for example, dementia.
ASSESSMENT OF DIETARY INTAKE AND NUTRITIONAL
STATUS
Participants completed three separate 24 hour recalls. These 24
hour recalls included one dialysis day, a non-dialysis weekday
and a non-dialysis weekend day. The mean of the three 24 hour
recalls taken to reflect usual intake for each of the following
nutrients: energy, carbohydrates, protein, total fat, saturated
fat, mono and polyunsaturated fat, dietary fibre and minerals
and vitamins. Usual intake was then compared to the EBPG (Ash
et al. 2006; National Health andMedical Research Council 2006;
Fouque et al. 2007; Ash et al. 2014). For energy and protein
requirements an adjusted body weight was calculated if the
participants’ body mass index (BMI) was not in the range of 23–
26 kg/m2. This adjusted body weight (ABW) was then used to
calculate requirements for energy and protein (Ash et al. 2006).
The patients’ dry weight (i.e. target weight post haemodialysis)
was used for all calculations. The Goldberg cut-off was used to
check for underreporting (Black 2000). The ratio of energy
intake/basal metabolic (BMR) rate was calculated using energy
requirements (Ash et al. 2006) multiplied by ABW for BMR. A
cut-off of >1.27 was used to define adequate reporting
(Martins et al. 2015). Foodworks software (version 7.0.3016,
Xyris software, Highgate Hill, Brisbane, Australia) was used for
nutrient analysis.
Participants also completed the polyunsaturated fatty acid
(PUFA) food frequency questionnaire (FFQ) (Sullivan et al. 2006)
with the assistance of the investigator. The PUFA FFQ (Sullivan
et al. 2006) was used to assess the PUFA intakes which was then
compared to the suggested dietary target (SDT) for chronic
disease reduction to determine the proportion of participants
meeting the SDT. The PUFA FFQ was also used to determine
primary food sources of n-3 LCPUFA for this cohort.
The Patient Generated Subjective Global Assessment (PG-SGA)
nutrition assessment tool was used to assess the nutritional
status of all participants (Bauer et al. 2002) and was
completed by the investigator (L.R). This involved a brief
medical history and also a physical assessment component.
The physical assessment evaluated fat, muscle and fluid status.
Nutritional status and number of nutrition impact symptoms
were recorded for each participant (Bauer et al. 2002).
Nutrition impact symptoms were measured by asking
participants what symptoms have impacted their food intake
over the previous two weeks, this included symptoms such as:
no appetite, nausea, vomiting and having a dry mouth (Bauer
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et al. 2002).The PG SGA has been validated for use in dialysis
patients in Australia (Desbrow et al. 2005).
DETERMINING DIET QUALITY
Diet Quality was determined using the Total Diet Score (TDS)
developed by Russell et al. (2013). This tool wasmodified for this
study using clinical judgement and EBPG (Ash et al. 2006) by an
experienced renal dietitian (author K.L) to reflect the appropriate
number of serves of each food group for patients undertaking
haemodialysis. Changes were made to scoring to reflect the
modified version for vegetables, fruit, wholegrains, meat, dairy
and percentage of saturated fat. The score was completed using
data obtained from the 24 hour recall data, with a maximum
possible score of 20. The TDS also included scoring for physical
activity, and points were allocated depending on the amount of
metabolic equivalents (METS) completed by the participant per
week. A questionnaire was used to assess physical activity
(Brown & Bauman 2000) and, METS were calculated using the
method of Brown and Bauman (2000).
STATISTICAL ANALYSIS
All data were tested for normality using the Shapiro Wilk test.
Data not normally distributed were log transformed and
retested for normality. The participants characteristics were
compared to the in centre HD cohort using independent t-test
for normal distributed data and Wilcoxon signed rank test for
non-normal data. Chi-squared tests were used for gender and
phosphate binder prescription between groups. The number of
participants meeting guidelines is expressed as proportions and
percentages. Correlations were conducted with Pearson’s
correlation for normally distributed data and Spearman’s
correlation for non-normal data. Differences in dietary intake
between participants reporting poor appetite and those with a
good appetite were assessed using independent t-test. Statisti-
cal significance was set at p<0.05. IBM SPSS Statistics for
Windows, Version 22.0. (Armonk, NY: IBM Corp.) was used for
statistical analysis.
ETHICAL APPROVAL
Ethics approval was granted from the University of Wollongong
Human Research Ethics Committee (Approval: HE 14/051).
RESULTS
Baseline characteristics of participants are outlined in Table 1.
Participants were excluded if they were incapable of answering
the questionnaires, this included participants with dementia or
other conditions effecting their memory and those that were ill
and were in a different ward during the study period. The
remaining patients not included in the study sample either did
not want to participate when approached or did not express
interest in the study. There were no significant differences in any
characteristics shown in Table 1 between the study sample
(n¼32) and the larger haemodialysis population (n¼101),
hence the sample was considered as a representative sample of
the total haemodialysis population.
DIETARY INTAKE
Table 2 shows the average daily intake for energy, macro-
nutrients and micronutrients, as well as the EBPG for the
nutrient where applicable, and the proportion of participants
adhering to that guideline. As shown in Table 2, no participants
met recommendations for saturated fat or carbohydrates. Only
6% of the participants met the recommendation for energy
intake, 28%met the recommendations for sodiumand 50%met
recommendations for protein. Dietary Fibre intakewas very poor
in comparison to Australian national recommendations (Na-
tional Health andMedical Research Council 2006). Regardless of
the amount of protein intake, 94% were consuming over half
their protein as a high biological value protein. Also 78% of
participants consumed a combined MUFA and PUFA intake of
less than 20% of their total energy intake. Adherence to the
majority of micronutrients according to guidelines were poor
with adherence ranging from 0% (Vitamin E) to 41% (Zinc).
Mean intake of potassium (0.70mmol/kg IBW) was much lower
than the recommended 1mmol/kg IBW (Ash et al. 2006). A total
of 31% of participants met the guideline for iron, but no female
participants met this guideline. The mean intake of vitamin B12
exceeded the recommendation. Only one participant was an
adequate reporter according to the >1.27 cut-off, the mean
ratio of energy intake to BMR was 0.690.24.
PUFA INTAKE
N-3 LCPUFA intake determined by the FFQ is found in Table 3.
Table 3 indicates that 22% of participants met the SDT for n-3
LCPUFA, with 40% of women meeting the SDT, and only 6% of
men meeting the SDT. The most common dietary sources of n-3
LCPUFA were fish (100% of participants consumed fish),
including canned fish, also red meat and chicken.
NUTRITIONAL STATUS
The PG SGA (n¼31) classified 39% of participants as well
nourished, 58% mild to moderately malnourished and 3%
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severely malnourished (Table 1). The nutrition impact symptoms
recorded by the PG SGA are outlined in Table 4. The most
common nutrition impact symptoms reported were poor
appetite (52%); dry mouth (42%), constipation (29%) and
problems with swallowing (29%). Only 16% of participants had
reported weight loss over the past two weeks (Table 1).
Participants that reported poor appetite (n¼ 16) had a
significantly lower TDS, and lower intakes of energy, protein
fibre and total n-3 LCPUFA than those participants that had a
good appetite (p<0.05).
DIET QUALITY
The mean TDS in this study was 10.2 (SD 1.8) out of score of 20,
the rangewas 6.8–13.9. All participants were in the low physical
activity category (Table 1), hence no participant received a point
in the TDS for physical activity. The TDSwas divided into quartiles
and all participant scores fell in the second (n¼ 13, 41%) and
third (n¼19, 59%) quartiles. No participants scored 15/20
indicating a high diet quality. There was a significant difference
between the mean TDS of the dialysis cohort in this study
compared to the mean of the original TDS study (Russell et al.
2013, Supplementary Information) of 9.3 (p¼ 0.005). The
range of scores in the original TDS was also wider: 2.97–15
(Russell et al. 2013). This original study was completed in a
healthy older Australian cohort (Russell et al. 2013).
There were positive correlations between TDS and n-3 LCPUFA
intake (r¼0.392, p< 0.05) and TDS and total omega-6 intake
(r¼0.363, p<0.05) as determined by Pearson correlation. No
correlation was found between TDS and BMI, weight, saturated
fat intake, monounsaturated fat intake and sugar intake.
DISCUSSION
In this study, we found that this haemodialysis cohort had poor
adherence to the EBPG for most macro and micronutrients. N-3
LCPUFA consumption was inadequate for most participants.
More than half of the group were assessed as malnourished and
the TDS indicated poor or suboptimal diet quality.
Of concern, saturated fat was in excess in all participants and
consistent with previous reports of a non-heart healthy diet
(Khoueiry et al. 2011; Luis et al. 2016). Also, only 6% of our
study participants had an adequate energy intake which is
consistent with previous reports (Luis et al. 2016). In our study
no participants consumed adequate carbohydrate, that is
between 50 and 60% of energy intake (Ash et al. 2006).
With only a small portion of participants meeting their energy
requirements, extra calories /kilojoules could be supplemented
from carbohydrate as well as protein. Only 50% of participants
met the recommended protein intake. Protein is especially
important in a dialysis population due to the high rates of
protein energy wasting (Qureshi et al. 1998). Considering mean
energy intake is low, protein may be used as an energy source in
this group (Stenvinkel et al. 2000). This would have deleterious
effects by contributing to malnutrition via a reduced lean body
mass (Chung et al. 2012). Saturated fat consumption in all
participants exceeded the recommendations, with food sources
Participants, n¼32 Larger dialysis cohort, n¼101 p-value
Age, years 73 (63, 79) 72 (58, 79) 0.564
Female, n (%) 15 (47) 46 (46) 0.895
Weight (kg) 8024 72 (60, 86) 0.294
BMI 29 (23, 34) 26 (23, 32) 0.247
Patients taking phosphate lowering binders% 81 82 0.855
Kt/V 1.60.4 1.6 (1.4, 1.8) 0.570
Well Nourished, n (%) 12 (39)
Mild to Moderately Malnourished, n (%) 18 (58)
Severely Malnourished, n (%) 1 (3)
Participants Reporting weight loss in the previous 2 weeks, n (%) 5 (16)
Participants reporting low physical activity levels (0–600 METS), n (%) 32 (100)
Adequate reporters, n (%) 1 (3)
Table 1: Characteristics of participants and larger dialysis cohort.1
BMI, Body Mass Index; Kt/V, dialysis adequacy.
1Values are frequency, median (25th, 75th percentile), or mean SD, n¼32 for participants, except for BMI n¼30, phosphate binder prescription
n¼31, Kt/V n¼31. n¼101 for larger dialysis cohort except for weight, n¼100, BMI n¼97, phosphate binder prescription n¼95 and Kt/V n¼98.
Determined by PG SGA.
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Macronutrients Daily intake EBPG







Energy, kcal/kg of ABW 20.57.09
Energy, kJ/kg of ABW 85.829.6 125–146 kJ/kg ABWa 2 (6%)
Carbohydrates, % of total energy 39.15.69 50–60% total energyb 0
Protein, % of total energy 22.34.96
Protein, g/kg of ABW 1.110.39 1.1g/kg ABWa 16 (50%)
High biological value protein (g) 55.620.2 >50% high biological value proteinb 30 (94%)
Fat, % of total energy 35.46.02
Saturated fat, % of total energy 14.23.88 <7% total energyb 0
Monounsaturated Fat, % of total energy 12.12.29
Polyunsaturated Fat, % of total energy 5.40 (4.49,
7.53)
Monounsaturated fat and polyunsaturated
fat, % of total energy
18.33.82 Monounsaturated fat, Polyunsaturated fat
<20% total energyb
25 (78%)
Dietary fibre, g 13.85.11
Micronutrients
Minerals
Phosphorus, mg 1053334 800–1000mgb 6 (19%)
Dietary calcium, mg 519195
Sodium, mg 1982 (1589,
2699)
1840–2530mgb 9 (28%)
Potassium, mg 1931640 –
Potassium, mmol/kg IBW 0.700.29 1mmol/kg IBWb
Iron, mg 8.272.92 8mg men, 15mg womenc 10 (31%) (all male)
Magnesium, mg 18863.3 420mg men, 320mg womend 0
Zinc, mg 9.654.67 10–15 men 13 (41%)
8–12 womenc
Water soluble vitamins
Thiamin (B1), mg 1.500.59 1.1–1.2mgc 5 (16%)
Riboflavin (B2), mg 1.460.64 1.1–1.3mgc 5 (16%)
Niacin (B3), mg 18.26.46 14–16mgc 3 (9%)
Folate (B9), mg 368151 1mgc
Cobalamin (B12), mg 3.491.87 2.4mgc




Vitamin A, mg 603366 700–900mgc 5 (16%)




Diet quality (Russell et al. 2013)
1st quartile – – 0 (0)
2nd quartile – – 13 (41)
3rd quartile – – 19 (59)
4th quartile – – 0 (0)
Table 2: Daily average intake from dialysis cohort (324h recalls).1
EBPG, Evidence Based Practice Guidelines, ABW, Adjusted Body Weight.
1Values expressed as mean SD for normally distributed data, and median (25th, 75th percentile) for non-normally distributed data, n¼32, for
secondary prevention of cardiovascular events and muscle cramps.
aRecommendation from Ash et al. (2014).
bRecommendation from Ash et al. (2006).
cRecommendation from Fouque et al. (2007).
dRecommendation from the Australian Nutrient Reference Values (National Health and Medical Research Council, 2006).
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of saturated fat predominately being full fat dairy foods (milk,
cheese and butter) and red meat.
Of interest, in this cohort of patients, fibre, potassium and folate
intake were lower than recommended levels, suggesting
participants may be overly restrictive and avoiding fruits,
vegetables and wholegrain cereals. This finding is in contrast
to others such as Luis et al. (2016) who found potassium intake
higher than recommended. Another particular problem identi-
fied in this cohort was iron intake in females, where no female
participants met the guideline. Bossola et al. (2014) also found
more women (78%) then men (58%) not meeting the guideline
for iron.
N-3 LCPUFA intakeswere comparedwith the recommended SDT
(National Health and Medical Research Council 2006). Only one
male participant (6%) met the SDT and six (40%) female
participants met the recommendations. This is of concern for
patients undergoing dialysis as they have an increased risk of
cardiovascular disease (Collins 2003). Even though the current
dialysis cohort has a much higher n-3 LCPUFA median intake of
359mg/day compared to the current adult Australian median
intake of 154mg/day (Meyer 2016), it is still lower than the SDT.
Furthermore, given that the dialysis cohort has a 40 fold
increased risk of heart disease (Collins 2003), and given the
cardioprotective effects of n-3 LCPUFA (Friedman et al. 2008),
increasing the n-3 LCPUFA intake would be beneficial in this
cohort of people on dialysis.
In this cohort, the primary food sources of n-3 LCPUFA were fish
(50% of total n-3 LCPUA was from fish), including canned fish,
and red meat and chicken. High consumption of canned fish
may be partially explained in this study by the fact that tuna
sandwiches are provided as an option for lunch at dialysis. Fish
consumption for patients is beneficial due to the high biological
value protein and the n-3 LCPUFA fats present (Castro-Gonzalez
et al. 2009).
The levels of malnutrition obtained via the PG SGA are
comparable with other levels published in the literature (Qureshi
et al. 1998; Tayyem et al. 2008; Chen et al. 2013). In the present
study 39% of the patients were assessed as well-nourished
compared with 32–38.3% in published literature (Tayyem et al.
2008; Chen et al. 2013), 58% were mild to moderately
malnourished, compared with 51–60% (Qureshi et al. 1998;
Chen et al. 2013) and 3%were severely malnourished compared
with 4.95–8% (Tayyem et al. 2008; Chen et al. 2013). The most
common nutrition impact symptoms were loss of appetite,
problems with swallowing, dry mouth and constipation
(Table 4). It is interesting to note, with a mean Kt/V of 1.6
(Table 1), that the majority of participants were adequately
dialysed (National Kidney 2015) and yet many reported poor
appetite. Participants who reported no appetite had a
significantly lower diet quality (p<0.05) and lower intakes of
energy, protein, fibre and n-3 LCPUFA (p<0.05) compared to
those not reporting poor appetite. The other frequently reported
PUFA Daily intake
Omega-6 fatty acids
LA, mg 9490 (6040, 14600)
AA, mg 142 (101, 199)
Omega-3 fatty acids
ALA, mg 1080 (755, 2210)
EPA, mg 108 (72.3, 194)
DPA, mg 74.538.7
DHA, mg 156 (90.3, 276)
Total long chain omega-3 359 (229, 548)
SDT long chain omega-3
Female mg/day 430
Male mg/day 610
Table 3: PUFA intake determined by the PUFA FFQ.1
PUFA, polyunsaturated fatty acid, FFQ, food frequency questionnaire,
LA, linoleic acid, AA, arachidonic acid, ALA, alpha linolenic acid, EPA,
eicosapentaenoic acid, DPA, docosapentaenoic acid DHA, docosahex-
aenoic acid, SDT, suggested dietary target.
1Values expressed as mean SD for normally distributed data, and
median (25th, 75th percentile) for non-normally distributed data.
Nutrition impact
symptom
Number of participants reporting
symptoms, N¼31 (%)
No appetite 16 (52)
Nausea 5 (16)
Constipation 9 (29)
Mouth sores 0 (0)
Things taste funny or
have no taste
2 (6)





Dry mouth 13 (42)
Smells bother me 1 (3)
Feel full quickly 5 (16)
Fatigue 1 (3)
Table 4: Nutrition Impact Symptoms reported in the PG SGA.1
PG SGA, Patient generated subjective global assessment.
1Values expressed as frequency of reported nutrition impact symptoms.
© 2017 European Dialysis and Transplant Nurses Association/European Renal Care Association Journal of Renal Care 2017 231
DIET QUALITY IN PATIENTS WITH END-STAGE KIDNEY
DISEASE UNDERGOING DIALYSIS
nutrition impact symptoms, dry mouth and swallowing
problems also make it difficult for patients to eat, thus reducing
total energy intake. Constipation was also reported in nearly a
third of participants, and this could be in part due to poor fibre
consumption. In this study, the daily fibre intake of study
participants was 13.8 g/day. This is significantly lower than
Australian nutrient reference value for fibre, which is 25 g/day
for women and 30g/day for men (National Health and Medical
Research Council 2006). Poor fibre intake may be due in part to
patients’ compliance to the low potassium diet which is often
characterised by reduced fruit, vegetable and wholegrain
consumption.
The mean value of the TDS in this study was 10.2 (1.8) with a
range of 6.8–13.9. The original TDS (Russell et al. 2013) was
used in an older Australian population, with a range of
2.97–15.40 out of 20, the mean TDS was 9.254. Although
the TDS in the haemodialysis cohort was significantly higher
than the mean score in the original healthy cohort, the results
still indicate that overall diet quality is suboptimal. Areas which
consistently scored well in this study were low alcohol intake,
low consumption of extra foods and low % of energy intake
from sugar. Areas of concern included inadequate intake of fruit
and vegetables and excessive intake of saturated fat and dairy
products.
The significantly higher TDS of the dialysis cohort than a normal
populationmay be partially explained by the fact that this cohort
is a closely monitored population and exposed to intense dietary
management. The EBPG suggests that patients BMI is assessed
monthly and dietary assessment should be completed every 3–6
months or more often if required (Ash et al. 2006). A survey of
renal dieticians found that nearly all respondents used the EBPG
to guide nutritional assessment, although only 55% undertook
six monthly nutritional assessments (Hall-McMahon & Campbell
2012). This dialysis population has regular dietary counselling
and assessment with a renal dietician.
There was a positive correlation between TDS and n-3 LCPUFA
intake as determined by the FFQ. This does not imply causation;
however, this does suggest that those with better diet quality
determined by the TDS are also consuming more n-3 LCPUFA.
There was also a positive correlation between omega-6 intake
and TDS, therefore it seems that consumption of both PUFA
resulted in a higher TDS. The original TDS study by Russell found
that there was an increase in fish consumption of 143%
between the lowest and highest quintiles of TDS (Russell et al.
2013), implying that those with a better diet quality consume
more fish, a major source of n-3 LCPUFA.
This study shows that there are still dietary improvements that
could be made in this population. These would include
increasing intake of energy from carbohydrates and protein,
whilst reducing consumption of saturated fats. Also, increasing
intake of most vitamins and minerals. However, strict dietary
allowances leading to frustrated patients (Kalantar-Zadeh et al.
2015) and nutritional impact symptoms such as loss of appetite
(Bossola et al. 2009) are all barriers to achieving this goal. Intake
of n-3 LCPUFA should also be improved, as there is evidence that
increased n-3 LCPUFA consumption reduces the risk of sudden
cardiac death in dialysis patients (Friedman et al. 2013).
Strategies should be undertaken to increase consumption of
n-3 LCPUFA rich foods or fish oil supplements.
In this study only 16% of participants reported a decline in body
weight in the previous two weeks despite only 6% achieving
adequate energy intake. This may be related to the fact that 97%
of participants in this study were considered under reporters for
energy intake, a commonly encountered issue in dietary studies
of haemodialysis patients when collecting dietary data via food
records (Noori et al. 2010; Mafra et al. 2012; Shapiro et al.
2015). This findingmay also be related to the increasing body of
evidence suggesting that the current energy requirements used
in EBPG actually overestimate requirements in a predominately
sedentary group (Kamimura et al. 2007).
Furthermore, the data used to evaluate adherence to the EBPG
were from three separate 24 hour recalls, and this is a well-
known limitation of dietary intake studies. A longer record of
dietary intake may have been more useful in evaluation of
nutrient intake in patients on dialysis (Chauveau et al. 2007) and
it has been suggested that a three days record may underesti-
mate fat intake (Noori et al. 2011). Memory and cognitive
impairment is another factor to be taken into account when
completing food recalls with an older haemodialysis cohort
(Cade et al. 2002; Lambert et al. 2016).
IMPLICATIONS FOR PRACTICE
This study provides a comprehensive overview of the diet quality
of a cohort of in-centre patients on dialysis and provides insight
into areas where specific improvements can be made. Further-
more we have adapted the total diet score to give a measure of
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diet quality, which can be used as a tool in monitoring diet in
dialysis patients in practice. Efforts to improve fruit, vegetable and
wholegrain cereal intake are needed to improve diet quality. This
study also provides novel findings on the physical activity levels
and LComega-3 intake inahaemodialysis cohortwhichmaybeof
use for further research and interventions in this group.
CONCLUSION
In conclusion, thedietary intakeof this haemodialysis cohortwasof
suboptimal quality,with specific improvements required; increased
consumption of energy, protein, carbohydrate, fibre, potassium
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